Actinium Pharmaceuticals

+$0.13 (+2.36%) Today
-$0.03 (-0.53%) As of 11:59 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ATNM and other ETFs, options, and stocks.

About ATNM

Actinium Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It engages in the development of novel targeted therapies known as Antibody Radiation-Conjugates, which combine the targeting ability of antibodies with the cell killing ability of radiation.

CEO
Sandesh Seth
Employees
32
Headquarters
New York, New York
Founded
2000

ATNM Key Statistics

Market cap
133.91M
Price-Earnings ratio
—
Dividend yield
—
Average volume
191.31K
High today
$5.63
Low today
$5.32
Open price
$5.50
Volume
219.57K
52 Week high
$10.30
52 Week low
$4.41

ATNM Earnings

-$0.37
-$0.25
-$0.12
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
— per share
Actual
-$0.23 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure